RxDoctor Payments DataLook up a doctor →

Sona Kamat, MD

Rheumatology · Saint Louis, MONPI 1407896129

Payments from drug & device makers

$930,968in general payments, 2019–2025

Across 1,388 payments — averaging $670.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$413K
  • Astrazeneca UK Limited$321K
  • Lilly USA, LLC$67K
  • Amgen$56K
  • Novartis$29K
  • UCB, Inc.$19K
  • plus $26K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$930,968 in reported general payments places this provider in the 95th percentile of 134 rheumatology providers in Missouri.

See all rheumatology providers in Missouri

Medicare billing

Part B allowed, 2024
$6,446,336
Medicare patients
546
Services billed
278,661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →